These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


65 related items for PubMed ID: 952359

  • 21. Alterations in atrial electrophysiology associated with chronic atrial fibrillation in man.
    Kamalvand K, Tan K, Lloyd G, Gill J, Bucknall C, Sulke N.
    Eur Heart J; 1999 Jun; 20(12):888-95. PubMed ID: 10329094
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Right ventricular monophasic action potentials in man. Effect of abrupt changes of cycle length and of atrial fibrillation.
    Olsson SB, Varnauskas E.
    Acta Med Scand; 1972 Mar; 191(3):159-66. PubMed ID: 4113670
    [No Abstract] [Full Text] [Related]

  • 24. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P, Tegelkamp R, Osada N, Schimpf R, Wolpert C, Breithardt G, Borggrefe M, Eckardt L.
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [Abstract] [Full Text] [Related]

  • 25. [Combination of quinidine and verapamil in auricular fibrillation].
    Sobrino JA, Maté I, Calvo L, Plaza I, Rico J, Moreno I, Mesa JM.
    Rev Esp Cardiol; 1989 Apr; 42(4):262-6. PubMed ID: 2781120
    [Abstract] [Full Text] [Related]

  • 26. Mechanoelectric feedback in the atrium of the isolated guinea-pig heart.
    Nazir SA, Lab MJ.
    Cardiovasc Res; 1996 Jul; 32(1):112-9. PubMed ID: 8776408
    [Abstract] [Full Text] [Related]

  • 27. [Atrial refractoriness and its dispersion in different physiopathologic conditions].
    Michelucci A, Padeletti L, Molino Lova R, Fradella GA, Monizzi D, Franchi F.
    G Ital Cardiol; 1982 Jul; 12(8):555-62. PubMed ID: 7169154
    [Abstract] [Full Text] [Related]

  • 28. [Expression of mineralocorticoid receptor and 11-beta-hydroxysteroid dehydrogenase type 2 in human atria during chronic atrial fibrillation: study of 25 cases].
    Pei DA, Li L, Xu ZY, Zou LJ, Zhang BR, Huang SD, Hao JH, Wang ZN, Lu FL.
    Zhonghua Yi Xue Za Zhi; 2007 Mar 27; 87(12):816-9. PubMed ID: 17565863
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr 27; 13(70):64-9. PubMed ID: 15148984
    [Abstract] [Full Text] [Related]

  • 31. [Cardiac dynamics in atrial fibrillation].
    Ungureanu G, Fotiade BC.
    Rev Med Chir Soc Med Nat Iasi; 1988 Apr 27; 92(2):239-46. PubMed ID: 3187230
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Antimuscarinic action of quinidine on the heart? A study in myocardial preparations from cat hearts.
    Nawrath H, Sack U, Zong X.
    Br J Pharmacol; 1984 Jan 27; 81(1):103-11. PubMed ID: 6704576
    [Abstract] [Full Text] [Related]

  • 35. Differential effects of quinidine and diphenylhydantoin on the monophasic action potential of the isolated rabbit heart.
    Dean RR.
    Life Sci; 1969 Jun 01; 8(11):633-42. PubMed ID: 5799283
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Are anticholinergic effects responsible for the heterogeneous quinidine-induced modifications of heart muscle refractoriness?
    Farges JP, Lièvre M, Ollagnier M, Faucon G.
    Experientia; 1978 May 15; 34(5):631-2. PubMed ID: 658252
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.